越野保健 CCRN 深 沪
已收盘 02-06 16:00:00 美东时间
8.69
-0.050
-0.57%
华盛通- 最 高8.85
- 今 开8.77
- 成交量 28.44万股
- 最 低 8.63
- 昨 收 8.74
- 总市值 2.85亿
- 52周最高 18.15
- 市盈率 静 --
- 换手率 0.87%
- 52周最低 7.43
- 委 比 -59.50%
- 总股本 3276.00万
- 历史最高 40.12
- 量 比 0.55
- 振 幅 2.52%
- 历史最低 3.76
- 每 手 1
- 风险率 2.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅213.87%！Wave Life Sciences获Canaccord Genuity升目标价至43美元，维持"买入"评级
今日重点评级关注：Canaccord Genuity：维持Wave Life Sciences Ltd."买入"评级，目标价从40美元升至43美元；花旗：维持Palantir Technologies"买入"评级，目标价从235美元升至260美元
02-04 12:15
Wedbush Initiates Coverage On Cross Country Healthcare with Neutral Rating, Announces Price Target of $11
Wedbush analyst Michael Piccolo initiates coverage on Cross Country Healthcare (NASDAQ:CCRN) with a Neutral rating and announces Price Target of $11.
02-04 00:26
Cross Country Sets Earlier Virtual 2026 Annual Meeting
An announcement from Cross Country Healthcare ( ($CCRN) ) is now available. Cro...
01-30 05:53
Cross Country Healthcare CEO John Martins Departs, Effective Immediately; Chairman Kevin Clark Named Successor
Co-Founder and Chairman, Kevin C. Clark, Returns as Chief Executive OfficerCross Country Healthcare, Inc. (the "Company" and "Cross Country") (NASDAQ:CCRN) today announced that John A. Martins, the Company's President
2025-12-15 21:19
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
Cross Country Healthcare shares are trading lower after the company terminated its merger agreement with Aya Healthcare.
Cross Country Healthcare shares are trading lower after the company terminated ...
2025-12-04 21:12
Cross Country Healthcare Terminates Aya Healthcare Merger; Aya Healthcare Required To Pay $20M Termination Fee; Cross Country Healthcare Commences $40M Buyback
Cross Country to Immediately Commence Share Repurchases Under Existing $40 million Authorization
2025-12-04 21:12
Cross Country Healthcare shares are trading lower after the company reported worse-than-expected Q3 financial results.
Cross Country Healthcare shares are trading lower after the company reported wo...
2025-11-13 21:53
Cross Country Healthcare Q3 Adj. EPS $0.03 Misses $0.04 Estimate, Sales $250.052M Miss $270.753M Estimate
Cross Country Healthcare (NASDAQ:CCRN) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.04 by 18.92 percent. This is a 75 percent decrease over earnings of $0.12 per share
2025-11-13 06:00
Cross Country Healthcare falls as FTC schedules meeting for next week
Cross Country Healthcare (NASDAQ:CCRN) dropped 17% after the Federal Trade Commission announced it would be holding a closed-door meeting on Wednesday. Although the exact topic of the meeting wasn't d...
2025-09-11 21:37
